Conozca los últimos avances en Alergia e Inmunología Clínica en el Congreso EAACI 2024, Valencia, España
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, España, March 19, 2024 (GLOBE NEWSWIRE) -- EAACI, Agencia Europea de Alergia e Inmunología...
Fique a par dos últimos desenvolvimentos nas áreas da Alergologia e Imunologia Clínica no Congresso da EAACI de 2024 em Valência, Espanha
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALÊNCIA, Espanha, March 19, 2024 (GLOBE NEWSWIRE) -- A Academia Europeia de Alergia e Imunologia...
2024 EAACI 학술대회, 알레르기 및 임상 면역학의 최신 동향을 주제로 스페인 발렌시아에서 개최
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 발렌시아, 스페인, March 19, 2024 (GLOBE NEWSWIRE) -- 전 세계 125개국에서 1만 6천 명 이상의 회원을 보유한 유럽 알레르기 임상 면역학회(European...
アレルギーと臨床免疫学の最新動向を、スペイン、バレンシアで開催される「EAACI Congress 2024」で網羅
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 スペイン、バレンシア発, March 19, 2024 (GLOBE NEWSWIRE) --...
Informieren Sie sich über die neuesten Entwicklungen auf dem Gebiet der Allergie und klinischen Immunologie auf dem EAACI-Kongress 2024 in Valencia, Spanien
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spanien, March 19, 2024 (GLOBE NEWSWIRE) -- Die Europäische Akademie für Allergologie und...
報導於西班牙華倫西亞舉行的 EAACI Congress 2024（2024 年度歐洲過敏及臨床免疫學會大會）中，過敏症及臨床免疫學的最新動態
19 mars 2024 07h42 HE
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 華倫西亞，西班牙, March 19, 2024 (GLOBE NEWSWIRE) -- 來自全球 125 個國家及地區，會員人數逾 16,000 人的 European Academy of Allergy...
Sema4 to Participate at Two Investor Conferences in June 2022
26 mai 2022 08h00 HE
|
Sema4
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 mai 2022 16h05 HE
|
Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
02 mai 2022 07h45 HE
|
Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...
Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
26 avr. 2022 16h05 HE
|
Sema4
STAMFORD, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for...